Hillström Anna, Hagman Ragnvi, Söder Josefin, Häggström Jens, Ljungvall Ingrid, Kjelgaard-Hansen Mads
Department of Clinical Sciences, Swedish University of Agricultural Sciences, Uppsala, Sweden (Hillström, Hagman, Häggström, Ljungvall)Department of Anatomy, Physiology and Biochemistry, Swedish University of Agricultural Sciences, Uppsala, Sweden (Söder)Translational Haemophilia Pharmacology, Novo Nordisk, Maaloev, Denmark (Kjelgaard-Hansen)
Department of Clinical Sciences, Swedish University of Agricultural Sciences, Uppsala, Sweden (Hillström, Hagman, Häggström, Ljungvall)Department of Anatomy, Physiology and Biochemistry, Swedish University of Agricultural Sciences, Uppsala, Sweden (Söder)Translational Haemophilia Pharmacology, Novo Nordisk, Maaloev, Denmark (Kjelgaard-Hansen).
J Vet Diagn Invest. 2015 Mar;27(2):182-90. doi: 10.1177/1040638715575751.
Measurement of low concentrations of C-reactive protein (CRP) in dogs has previously been performed with nonautomated assays. The aim of this study was to validate an automated high-sensitivity CRP (hsCRP) assay, developed by modifying a routinely used canine-specific immunoturbidimetric CRP test (cCRP). Imprecision, linearity under dilution, limit of blank (LOB), limit of detection (LOD), and limit of quantification (LOQ) were determined for the hsCRP test, as well as the presence of prozone effect and interferences. The imprecision, measured as intra-assay variation, was ≤2.7%. The assay was acceptably linear under dilution. An analytically relevant prozone effect was present for samples with CRP concentration >150 mg/L, and there were mild interferences from hemolysis and lipemia. The LOB, LOD, and LOQ were 0.10 mg/L, 0.22 mg/L, and 0.50 mg/L, respectively. A method comparison study with a canine-specific enzyme-linked immunosorbent assay (ELISA) was performed, showing poor agreement between the hsCRP test and the ELISA. An additional aim of the study was to apply the hsCRP test to clinical research samples. Serum samples from 7 dogs undergoing ovariohysterectomy were collected pre- and postoperatively, and CRP was measured with both the cCRP and hsCRP assay. The expected postoperative increase in CRP was detected earlier with the hsCRP test, compared with the cCRP test. The hsCRP assay was further applied on samples from 6 lean and 9 overweight dogs. There was no significant difference in CRP concentration between the groups (P = 0.06). In conclusion, the hsCRP test had acceptable analytical performance, and the assay was successfully applied to clinical research samples.
此前,犬类低浓度C反应蛋白(CRP)的检测一直采用非自动化检测方法。本研究的目的是验证一种通过改良常规使用的犬特异性免疫比浊法CRP检测(cCRP)开发的自动化高敏CRP(hsCRP)检测方法。测定了hsCRP检测方法的不精密度、稀释线性、空白限(LOB)、检测限(LOD)和定量限(LOQ),以及前带效应和干扰的存在情况。以批内变异衡量的不精密度≤2.7%。该检测方法在稀释情况下具有可接受的线性。对于CRP浓度>150 mg/L的样本存在分析相关的前带效应,并且溶血和脂血存在轻度干扰。LOB、LOD和LOQ分别为0.10 mg/L、0.22 mg/L和0.50 mg/L。进行了一项与犬特异性酶联免疫吸附测定(ELISA)的方法比较研究,结果显示hsCRP检测与ELISA之间的一致性较差。本研究的另一个目的是将hsCRP检测应用于临床研究样本。收集了7只接受卵巢子宫切除术的犬术前和术后的血清样本,并用cCRP和hsCRP检测方法测量了CRP。与cCRP检测相比,hsCRP检测更早地检测到了术后CRP预期的升高。hsCRP检测进一步应用于6只瘦犬和9只超重犬的样本。两组之间的CRP浓度没有显著差异(P = 0.06)。总之,hsCRP检测具有可接受的分析性能,并且该检测方法成功应用于临床研究样本。